Editorial: only steps away from primetime? Hepatitis B virus RNA as a routine marker to guide HBV treatment decisions—authors' reply,Alimentary Pharmacology & Therapeutics

当前位置： X-MOL 学术 › Aliment. Pharm. Ther. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Editorial: only steps away from primetime? Hepatitis B virus RNA as a routine marker to guide HBV treatment decisions—authors' reply
Alimentary Pharmacology & Therapeutics ( IF 6.6 ) Pub Date : 2021-09-10 , DOI: 10.1111/apt.16570
Muye Xia ₁ , Heng Chi ₂ , Harry L A Janssen ₃ , Jie Peng ₁

Affiliation

This article is linked to Xia et al and Wehmeyer & Schulze zur Wiesch papers. To view these articles, visit https://doi.org/10.1111/apt.16538 and https://doi.org/10.1111/apt.16560

中文翻译：

社论：距离黄金时段仅几步之遥？乙型肝炎病毒 RNA 作为指导 HBV 治疗决策的常规标志物——作者的答复

本文链接到 Xia 等人和 Wehmeyer & Schulze zur Wiesch 的论文。要查看这些文章，请访问 https://doi.org/10.1111/apt.16538 和 https://doi.org/10.1111/apt.16560

更新日期：2021-09-12

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南11